Bringing personalized medicine to reproductive health
Offer the test at your clinic

The world’s first multi-gene

genetic test for reproductive health

The Fertilome test is a next generation sequencing panel that reveals genetic factors significantly associated with the most common reproductive conditions in women.
00:00:00/00:00:00

Defining a new category of genetic tests

Unlike carrier screening tests, which look at the health risks for a baby, the Fertilome test is the first genetic screen that examines a woman’s genetic signature and how it may impact her reproductive health and ability to conceive, today and in the future.

How the Fertilome test can work for you

By revealing genetic risk factors, the Fertilome test enables more refined diagnoses and treatment decisions than physical examinations or existing diagnostic tests alone. Using the genetic test can help you frame conversations around reproductive health and family building as a proactive journey.

Identify subclinical factors

Refine treatment plans

Counsel women with family history

Counsel egg freezing candidates

Guide targeted lifestyle counseling

The science behind our test

The Fertilome test analyzes 49 variants in 32 genes associated with a spectrum of female reproductive conditions. The Fertilome panel was developed through a systematic literature review and statistical meta-analysis.

Take the next step

The Fertilome genetic screen is a blood test that can be ordered by a physician. The test is available in all U.S. states. and billed directly to the patient. The Fertilome genetic screen is a laboratory developed test run by Celmatix Clinical Laboratories.2

For physicians

Interested in offering the Fertilome test at your practice? Contact our team today.

For patients

Interested in asking your provider about the Fertilome test? Download a discussion guide to share with your physician for ordering.

1. https://clinicalgenome.org/site/assets/ les/2657/current_clinical_validity_classi cations.pdf

2. The Fertilome test was developed and its performance characteristics determined by Celmatix Clinical Laboratories, a laboratory regulated under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high-complexity clinical testing and the test has been analytically validated in accordance with CLIA standards. Fertilome has not been cleared or approved by the US Food and Drug Administration. At this time, physicians of NY, FL, MD, RI, PA, and CA residents may request Fertilome under New York State Department of Health's NPL process.

Interested in taking a Fertilome test?